Important Reasons Behind the Success of Pharma Industry in India
Have you ever picked up any strip of medicine and wondered, “Where was this actually made?” Chances are, there’s a great possibility it came from India. Yes, India is one of the largest pharma industries, and the reasons behind the success of the pharma industry in India are not that it happened overnight. It is a story of years of learning, improving and earning trust.
From manufacturing affordable generic medicines to producing life-saving vaccines, India has exported pharmaceutical products to more than 200 countries, valued at US$30.47 billion. Every successful milestone has been backed by skilled scientists, advanced manufacturing facilities and a strong focus on quality.
Today, the pharma industry in India is playing a vital role in improving healthcare across the globe, but do you know what exactly helped India become the “Pharmacy of the World”? Is it affordable manufacturing, government initiatives or a highly skilled workforce? In this article, we’ll explore the important reasons behind the success of the pharma industry in India. Stay Connected.

Table of Contents
Have a Look at the Numbers that Show Success of the Pharma Industry in India
- India’s pharmaceutical industry ranks 3rd globally by volume and 11th by value, with more than 3,000 companies and 10,500 manufacturing units, as per data shown by PIB.
- The pharmaceutical market of India is valued at USD 60.32 billion in 2026 and expected to reach USD 79.74 billion by 2031, according to data shown by Mordor Intelligence.
- The Indian pharmaceutical manufacturing market value was valued at USD 20.6 billion in 2025, and it is projected to reach USD 36.5 billion by 2034, as per data shown by IMARC Group.
Top 10 Reasons Behind the Success of the Pharma Industry in India

Affordable Medicines Without Compromising on Quality
“You get quality that fits every budget”
Behind the success of the pharma industry in India, there is a big reason- the ability to manufacture high-quality medicines at highly competitive prices. Medicine in many developed countries can be expensive, but Indian pharma companies have found the perfect balance of affordability and quality without compromising patient safety.
This cost advantage of medicines in India comes from multiple factors such as skilled workforce, large-scale production facilities, efficient manufacturing process and strong availability of raw materials. This results in an Indian company that can produce medicines at a lower cost while complying with standards such as WHO-GMP, US FDA, GMP and more.
A Strong Foundation Built on Generic Medicines
“Making healthcare more accessible, one medicine at a time”
As we all know, India is widely known as the “Pharmacy of the World” because of its leadership in generic medicine manufacturing. In generic medicine, the same active ingredients, safety profile, dosage and therapeutic effectiveness are present as branded medicines, but these are available at significantly lower prices. Today, India is the largest supplier of generic medicines by volume.
Due to the availability of affordable generic medicine, India’s pharma industry has transformed to reduce treatment costs and improve access to essential medicines for millions of people.
Skilled Scientists & Pharmaceutical Professionals
“A brilliant mind of India behind every trusted medicine”
Behind every final medicine, there is a dedicated team of scientists, pharmacists, microbiologists, chemists, regulatory specialists and quality assurance professionals. India offers one of the largest pools of pharma and life sciences graduates every year. These professionals play a vital role in drug formulation, clinical research, quality control, regulatory compliance, biotechnology research, vaccine development and pharmaceutical engineering.
Manufacturing Facilities that Meet Global Standards
“India- Where quality is built into every process”
India has already developed one of the strongest pharmaceutical manufacturing infrastructures in the world. That means thousands of manufacturing facilities operate with advanced automation, modern production equipment and stringent quality control systems.
There are many pharmaceutical plants in India that are approved by globally recognized regulatory agencies such as WHO-GMP, US FDA, UK MHRA, EU GMP, TGA Australia and more. In India, every stage of manufacturing is monitored through strict quality assurance protocols.
Government Policies that Encouraged Growth
“The Government of India also support pharma industry”
Behind the transformation of India’s pharma industry, there is the government, which plays a significant role. The government takes several initiatives that encourage domestic manufacturing, innovation, exports and self-reliance. Here, we are sharing some major government initiatives, including:
- Production Linked Incentive Scheme
- Promotion of Bulk Drug Parks
- Strengthening domestic API manufacturing
The Indian Government really supports Pharma companies and encourages investments in pharmaceutical research, biotechnology and export promotion.
Continuous Investment in Research & Innovation
“Today’s innovation shapes the medicine of tomorrow”
Indian pharma companies are evolving rapidly because they understand that long-term success depends on innovation. That’s why, instead of focusing only on manufacturing, pharma companies are investing in new drug development, biosimilars, biotechnology, vaccine research, novel drug delivery systems and more.
A Diverse Product Portfolio that Meets Every Healthcare Need

“One industry and countless healthcare solutions”
This is another major reason behind the success of the pharma industry in India- a diverse product portfolio. Today, Indian pharmaceutical manufacturers are not just limited to producing just tablets or capsules; they cater to almost every segment of healthcare, such as:
- Tablets
- Capsules
- Dry syrups
- Creams
- Ointments
- Syrups
- Eye and ear drops
- Nutraceuticals
- Ayurvedic medicines
- Oncology medicines
- Veterinary medicines
- Critical care products and more.
Rise of Third-Party Pharma Manufacturing
“Helping brands grow without building factories”
In India, third-party manufacturing has become one of the fastest-growing business models that contributes to the success of the pharma industry in India. Multiple pharma manufacturing companies invest in third-party manufacturing due to its low investment and high returns.
This model offers various advantages, such as:
- Lower capital investment
- Faster product launches
- High manufacturing quality
- Regulatory compliance
- Flexible production volumes
- Reduces operational risks
It shows India has become one of the preferred destinations for contract manufacturing because of its manufacturing expertise, competitive pricing and ability to produce medicines as per international standards.
A Thriving API & Bulk Drug Ecosystem
“A strong foundation always creates stronger medicines”
Every medicine manufacturing begins with an Active Pharmaceutical Ingredient (API)– one of the components responsible for its therapeutic effect. India has already strengthened its API and bulk drug manufacturing capabilities in recent years. A well-established API ecosystem offers several advantages:
- Greater control over the pharmaceutical supply chain
- Reduce manufacturing costs
- Faster production timelines
- Improve the availability of essential medicines
- Enhance resilience during global supply disruptions
India is now building a more self-reliant pharma industry by expanding its domestic API production.
A Robust Regulatory Framework that Builds Global Confidence
“Trust always begins with transparency and compliance”
The global success of the Indian pharma industry is not just built on manufacturing excellence but also on a strong regulatory system that ensures medicines are safe, effective, and consistently meet quality standards. The CDSCO of India is operating under the Ministry of Health & Family Welfare, which regulates the approval, manufacturing, testing and quality of pharma products in India.
Many pharmaceutical manufacturers in India undergo regular inspections by international regulatory authorities. Overall. Indian pharma companies follow a transparent and robust regulatory framework that has strengthened international confidence in Indian pharmaceutical products.
Frequently Asked Questions about Important Reasons Behind the Success of the Pharma Industry in India
Question. What countries majorly import pharmaceutical products from India?
Answer: India exports their pharmaceutical products to more than 200 countries. Some majors are:
- United State
- United Kingdom
- South Africa
- Brazil
- Germany
- Russia
- France
- Canada
- Nigeria
- UAE
- Nepal
- Sri Lanka
Question. Why is the cost of Indian pharmaceutical manufacturing lower than in many countries?
Answer: Indian pharmaceutical manufacturing is more affordable because it offers several competitive advantages such as lower labour costs, a highly skilled workforce, large-scale production facilities and a well-established pharmaceutical ecosystem.
Question. Is there a chance to grow more of the Indian pharma industry?
Answer: Yes, the future of the Indian pharma industry is highly promising. As per some data, the Indian pharmaceutical market is expected to reach US$130 billion by 2030.
Question. How do Indian pharma companies maintain global competitiveness?
Answer: Indian pharmaceutical companies always remain globally competitive by continuously investing in research & development, upgrading manufacturing facilities, complying with international regulatory standards and adopting advanced technology.
Question. What opportunities are available for entrepreneurs in India’s pharmaceutical industry?
Answer: Multiple opportunities are available in India’s pharmaceutical industry, such as:
- PCD pharma franchise
- Third-party pharmaceutical manufacturing
- Contract manufacturing
- API (Active Pharmaceutical Ingredient) Manufacturing
- Nutraceutical Manufacturing
- Ayurvedic Manufacturing and more.
Question. What therapeutic segments are showing the growth of India’s pharmaceutical industry?
Answer: Several therapeutic segments are currently contributing to the growth of the Indian pharma industry. It includes:
- Cardiology
- Diabetes Care
- Oncology
- Neurology
- Orthopedics
- Vaccines
- Nephrology
- Nutraceuticals
